Mohan, Managing Director, Orbicular Pharmaceutical Technologies, said: "Receiving Notice of Compliance from Health Canada, following the U.S
This shift can lower physical activity, possibly causing some weight gain down the line
The mean index weight was similar between the two cohorts, with patients who were treated with semaglutide 2.4 mg averaging 104.5 kg and those who were treated with tirzepatide averaging 104.9 kg
To find out more about how Ipamorelin therapy can benefit you, schedule a consultation with one of our experts
GLP-1 medications improve insulin levels while they're being taken, but there is no evidence that insulin resistance remains permanently within a healthy range with long-term use
Long-Term Considerations For individuals needing ongoing support in maintaining healthy habits, continuing semaglutide at a lower maintenance dosage is a viable option with minimal long-term risks